Differential cell death programmes induced by silver dressings in vitro

European Journal of Dermatology

Volumn 18, Issue 4, 2008, Pages 416-421

  Van Den Plas, Dave ^a   De Smet, Kris ^a   Lens, Dimitri ^a   Sollie, Philippe ^a  

^a Flen Pharma nv   (Belgium)

Author keywords

Cytotoxicity; Silver; Wound healing

Indexed keywords

CALCIUM ALGINATE; CARBOXYMETHYLCELLULOSE; COMFEEL; NANOCRYSTAL; SILVER DERIVATIVE;

ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CELL DEATH; CELL SURVIVAL; CELL TYPE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ESCHERICHIA COLI; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; WOUND DRESSING;

ANTI-INFECTIVE AGENTS; BANDAGES; CELL DEATH; CELLS, CULTURED; HUMANS; SILVER;

EID: 47749136178     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0437     Document Type: Article

References (18)

1. Robson MC. Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 1997; 77(3): 637-50.
2. Robson MC. Infection in the surgical patient: an imbalance in the normal equilibrium. Clin Plast Surg 1979; 6(4): 493-503.
3. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns 2007; 33(2): 139-48.
4. Warriner R, Burrell R. Infection and the chronic wound: a focus on silver. Adv Skin Wound Care 2005; 18(Suppl 1): 2-12.
5. Moyer CA, Brentano L, Gravens DL, Margraf HW, Monafo WW. Treatment of large human burns with 0.5% silver nitrate solution. Arch Surg 1965; 90: 812-67.
6. Stanford W, Rappole BW, Fox Jr. CL. Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns. J Trauma 1969; 9(5): 377-88.
7. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2000; 26(2): 131-8.
8. Bader KF. Organ deposition of silver following silver nitrate therapy of burns. Plast Reconstr Surg 1966; 37(6): 550-1.
9. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 2005; 19(7): 975-83.
10. Poon VK, Burd A. In vitro cytotoxity of silver: implication for clinical wound care. Burns 2004; 30(2): 140-7.
11. Lam PK, Chan ES, Ho WS, Liew CT. In vitro cytotoxicity testing of a nanocrystalline silver dressing (Acticoat) on cultured keratinocytes. Br J Biomed Sci 2004; 61(3): 125-7.
12. Teraki Y, Shiohara T. Apoptosis and the skin. Eur J Dermatol 1999; 9(5): 413-25.
13. Birringer R. Nanocrystalline materials. Mater Sci Eng 1989; A117: 33-43.
14. Burd A, Kwok CH, Hung SC, Chan HS, Gu H, Lam WK, Huang L. A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair Regen 2007; 15(1): 94-104.
15. Brett DW. A discussion of silver as an antimicrobial agent: alleviating the confusion. Ostomy Wound Manage 2006; 52(1): 34-41.
16. Walker M, Cochrane CA, Bowler PG, Parsons D, Bradshaw P. Silver deposition and tissue staining associated with wound dressings containing silver. Ostomy Wound Manage 2006; 52(1): 46-50.
17. Dioki SS, Burrell RE, Field DJ. An electrochemical analysis of thin silver films produced by reactive sputtering. J Electrochem Soc 2001; 148(3): 191-6.
18. Taylor PL, Omotoso P, Wiskel JB, Mitlin D, Burrell RE. Impact of heat on nanocrystalline silver dressings. Part II. Physical properties. Biomaterials 2005; 26(35): 7230-40.